Research & Clinical Studies
For restoreGen™ (KB220Z)
Most Recent Research
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/24878765/?i=9&from=blum%20k%20and%20GARS
Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional C... - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/29214221/?i=8&from=blum%20k%20and%20GARS
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)
https://www.ncbi.nlm.nih.gov/m/pubmed/28033474/?i=7&from=blum%20k%20and%20GARS
The Benefits of Customized DNA Directed Nutrition To Balance The Brain Reward Circuitry And Reduce Addictive Behaviors - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28066828/?i=6&from=blum%20k%20and%20GARS
Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Pattern - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28090374/?i=5&from=blum%20k%20and%20GARS
Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28804788/?i=4&from=blum%20k%20and%20GARS
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence. - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28930612/?i=3&from=blum%20k%20and%20GARS
Global Opioid Epidemic: Doomed To Fail Without Genetically Based Precision Addiction Medicine (Pam™): Lessons Learned From America. - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/29372187/?i=2&from=blum%20k%20and%20GARS
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD). - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/29399668/?i=1&from=blum%20k%20and%20GARS
https://www.ncbi.nlm.nih.gov/m/pubmed/24878765/?i=9&from=blum%20k%20and%20GARS
Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional C... - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/29214221/?i=8&from=blum%20k%20and%20GARS
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)
https://www.ncbi.nlm.nih.gov/m/pubmed/28033474/?i=7&from=blum%20k%20and%20GARS
The Benefits of Customized DNA Directed Nutrition To Balance The Brain Reward Circuitry And Reduce Addictive Behaviors - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28066828/?i=6&from=blum%20k%20and%20GARS
Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Pattern - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28090374/?i=5&from=blum%20k%20and%20GARS
Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28804788/?i=4&from=blum%20k%20and%20GARS
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence. - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/28930612/?i=3&from=blum%20k%20and%20GARS
Global Opioid Epidemic: Doomed To Fail Without Genetically Based Precision Addiction Medicine (Pam™): Lessons Learned From America. - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/29372187/?i=2&from=blum%20k%20and%20GARS
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD). - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/m/pubmed/29399668/?i=1&from=blum%20k%20and%20GARS
Earlier KB220Z Research
Reward Deficiency Syndrome Studies of KB220 Variants and Molecular Neurobiology
https://static.secure.website/wscfus/10065079/5663593/rds-kb220z-research-formatted-5617.pdf
Click on these links for more research on KB220Z
https://www.ncbi.nlm.nih.gov/pubmed/27840857
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264422/
Research - Pro-Dopamine Regulator - (KB220Z) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
Research - The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. - PubMed - NCBI
Research - Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z
Research - rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. - PubMed - NCBI
Research - Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? - PubMed - NCBI
Research - Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome? - PubMed - NCBI
Research - Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior. - PubMed - NCBI
Research - The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity. - PubMed - NCBI
Research - Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery La... - PubMed - NCBI
Research - Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. - PubMed - NCBI
Research - Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD case. - PubMed - NCBI
Research - Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. - PubMed - NCBI
Research - KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes... - PubMed - NCBI
Research -Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission. - PubMed - NCBI
Research - Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative - PubMed - NCBI
Research - A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy... - PubMed - NCBI
Research - Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? - PubMed - NCBI
Research - Neuronutrient Amino-Acid Therapy - Sept 2016
Research - Long Term Use Sept 2016
Research - Clinical Medical Reviews - Detox
https://static.secure.website/wscfus/10065079/5663593/rds-kb220z-research-formatted-5617.pdf
Click on these links for more research on KB220Z
https://www.ncbi.nlm.nih.gov/pubmed/27840857
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264422/
Research - Pro-Dopamine Regulator - (KB220Z) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
Research - The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. - PubMed - NCBI
Research - Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z
Research - rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. - PubMed - NCBI
Research - Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? - PubMed - NCBI
Research - Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome? - PubMed - NCBI
Research - Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior. - PubMed - NCBI
Research - The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity. - PubMed - NCBI
Research - Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery La... - PubMed - NCBI
Research - Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. - PubMed - NCBI
Research - Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD case. - PubMed - NCBI
Research - Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. - PubMed - NCBI
Research - KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes... - PubMed - NCBI
Research -Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission. - PubMed - NCBI
Research - Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative - PubMed - NCBI
Research - A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy... - PubMed - NCBI
Research - Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? - PubMed - NCBI
Research - Neuronutrient Amino-Acid Therapy - Sept 2016
Research - Long Term Use Sept 2016
Research - Clinical Medical Reviews - Detox
